TABLE 3.
Parameter | Value for:
|
||||
---|---|---|---|---|---|
3T3 cells
|
cos7 cells
|
||||
ori mutant without TSA (n = 121; silent)b | ori mutant with TSA (n = 123; active) | ori mutant without TSA (n = 78; silent) | ori mutant with TSA (n = 31; active) | ori† without TSA (n = 64; active) | |
No. of nuclei containing the following no. of VLPs | |||||
0 | 72 | 89 | 42 | 10 | 25 |
1 | 26 | 22 | 21 | 8 | 19 |
2 | 13 | 9 | 11 | 4 | 12 |
3 | 7 | 2 | 2 | 3 | 2 |
4 | 2 | 0 | 1 | 3 | 2 |
5 | 1 | 1 | 1 | 3 | 2 |
6 | 0 | 0 | 0 | 0 | 1 |
7 | 0 | 0 | 0 | 0 | 0 |
8 | 0 | 0 | 0 | 0 | 1 |
% of nuclei with VLPs | 40.5 | 27.6 | 46.2 | 67.7 | 60.9 |
Avg. no. of VLPs/nucleusc | 1.75 | 1.5 | 1.58 | 2.48 | 2.07 |
Number of Cy3-fluorescent VLPs counted (as described in the legend for Fig. 2) in 3T3 or cos7 cells with VLPs carrying either ori-mutant or ori+ pDNA and incubated with or without TSA.
The expression status was determined by luciferase assays of parallel cultures and is indicated as active or silent. n, total number of nuclei counted per cell line and treatment.
Calculated for VLP-positive nuclei only.